Table 1 Healthy individuals and rectal cancer (RC) patients’ characteristics
From: Distinct increased outliers among 136 rectal cancer patients assessed by γH2AX
Number of individuals | Mean/median age | Pathologic stage (UICC) 1/2/3/4 (%) | Chemotherapy 5-FU/5-Fu + Oxa/Irinotecan/5-FU + Irinotecan (%) | Lymph node metastasis yes/no (%) | Total RT dose (Gy) | |
|---|---|---|---|---|---|---|
Healthy individuals | 59 | 56.0/58.5 | ||||
Patients | 136 | 63.7/66.0 | 0/8.1/75.7/16.2 | 25.7/64.5/2.9/3.7 | 89.5/10.5 | 50.4 |